<HashMap><database>NODE</database><scores/><additional><omics_type>Genomics</omics_type><submitter>Chunmei Kuang</submitter><technology_type>ATAC-seq</technology_type><full_dataset_link>https://www.biosino.org/node/experiment/detail/OEX00016790</full_dataset_link><experiment_platform>Illumina HiSeq 2500</experiment_platform><experiment_library_layout>Paired</experiment_library_layout><experiment_library_selection>PCR</experiment_library_selection><sample_count>2</sample_count><tissue>['cord Blood']</tissue><taxonomy>['Homo sapiens']</taxonomy><experiment_protocol>50000 MKs treated with vehicle or serine at day 12  were collected for ATAC-seq (Novogene, China).</experiment_protocol><repository>NODE</repository></additional><is_claimable>false</is_claimable><name>OEX_Chunmei_2204302123</name><description>we identify serine serves as a key metabolic factor that suppresses megakaryopoiesis and thrombopoiesis and eventually causes the thrombocytopenia in multiple myeloma. To identify the potential methylated substrates regulated by serine, we performed assay for transposase-accessible chromatin using sequencing (ATAC-seq) in MKs treated with vehicle or serine at day 12.</description><dates><publication>2022-12-19</publication><submission>2022-04-30</submission></dates><accession>OEX00016790</accession><cross_references><NODE>OEP00003357</NODE></cross_references></HashMap>